Boston Partners Novartis Ag Transaction History

Boston Partners

$80.6 Billion
Q3 2024

A detailed history of Boston Partners transactions in Novartis Ag stock. As of the latest transaction made, Boston Partners holds 37,039 shares of NVS stock, worth $3.65 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

37,039

Previous 35,467 4.43%

Holding current value

$3.65 Million

Previous $3.78 Million 12.85%

% of portfolio

0.01%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$106.13 - $120.89 $166,836 - $190,039	1,572 Added 4.43%	37,039 $4.26 Million
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $1.62 Million - $1.87 Million	17,450 Added 96.85%	35,467 $3.78 Million
Q1 2024 May 13, 2024	SELL	$95.27 - $108.47 $1.31 Million - $1.49 Million	-13,759 Reduced 43.3%	18,017 $1.74 Million
Q4 2023 Feb 07, 2024	BUY	$92.27 - $101.54 $169,407 - $186,427	1,836 Added 6.13%	31,776 $3.21 Million
Q3 2023 Nov 07, 2023	BUY	$94.73 - $105.13 $213,142 - $236,542	2,250 Added 8.13%	29,940 $3.05 Million
Q1 2023 May 09, 2023	SELL	$80.03 - $92.81 $192,872 - $223,672	-2,410 Reduced 8.01%	27,690 $2.55 Million
Q4 2022 Feb 07, 2023	SELL	$75.55 - $92.52 $132 Million - $161 Million	-1,742,349 Reduced 98.3%	30,100 $2.73 Million
Q3 2022 Nov 09, 2022	SELL	$74.61 - $87.26 $210 Million - $245 Million	-2,811,869 Reduced 61.34%	1,772,449 $135 Million
Q2 2022 Aug 10, 2022	SELL	$80.52 - $93.75 $2.08 Million - $2.42 Million	-25,857 Reduced 0.56%	4,584,318 $388 Million
Q1 2022 May 10, 2022	SELL	$80.11 - $90.62 $5.39 Million - $6.09 Million	-67,228 Reduced 1.44%	4,610,175 $405 Million
Q4 2021 Feb 04, 2022	BUY	$79.7 - $88.13 $23.3 Million - $25.8 Million	292,854 Added 6.68%	4,677,403 $409 Million
Q3 2021 Nov 05, 2021	SELL	$81.78 - $95.14 $157 Million - $182 Million	-1,915,211 Reduced 30.4%	4,384,549 $359 Million
Q2 2021 Aug 12, 2021	BUY	$85.24 - $94.15 $37.4 Million - $41.3 Million	439,189 Added 7.49%	6,299,760 $575 Million
Q1 2021 May 10, 2021	SELL	$83.5 - $98.47 $15.9 Million - $18.8 Million	-190,564 Reduced 3.15%	5,860,571 $501 Million
Q4 2020 Feb 04, 2021	SELL	$78.07 - $94.43 $17.7 Million - $21.5 Million	-227,345 Reduced 3.62%	6,051,135 $571 Million
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $30.7 Million - $34 Million	-374,043 Reduced 5.62%	6,278,480 $546 Million
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $272 Million - $306 Million	3,359,705 Added 102.03%	6,652,523 $581 Million
Q1 2020 May 13, 2020	BUY	$70.67 - $99.01 $110 Million - $154 Million	1,560,022 Added 90.03%	3,292,818 $271 Million
Q4 2019 Feb 05, 2020	SELL	$84.35 - $95.37 $14.7 Million - $16.6 Million	-174,425 Reduced 9.15%	1,732,796 $164 Million
Q3 2019 Nov 20, 2019	SELL	$85.54 - $94.26 $167 Million - $184 Million	-1,957,025 Reduced 50.64%	1,907,221 $166 Million
Q3 2019 Nov 08, 2019	SELL	$85.54 - $94.26 $4.99 Million - $5.5 Million	-58,314 Reduced 1.49%	3,864,246 $353 Million
Q2 2019 Aug 26, 2019	SELL	$75.4 - $92.8 $11,008 - $13,548	-146 Reduced -0.0%	3,922,560 $358 Million
Q2 2019 Aug 09, 2019	SELL	$75.4 - $92.8 $191 Million - $236 Million	-2,539,702 Reduced 39.3%	3,922,706 $358 Million
Q1 2019 May 03, 2019	SELL	$75.32 - $86.15 $44 Million - $50.3 Million	-584,386 Reduced 8.29%	6,462,408 $621 Million
Q4 2018 Feb 07, 2019	BUY	$73.66 - $82.02 $108 Million - $120 Million	1,459,845 Added 26.13%	7,046,794 $605 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $1.32 Million - $1.52 Million	-19,681 Reduced 0.35%	5,586,949 $481 Million
Q2 2018 Aug 03, 2018	BUY	$64.91 - $73.36 $187 Million - $212 Million	2,885,436 Added 106.04%	5,606,630 $424 Million
Q1 2018 May 04, 2018	BUY	$70.39 - $84.15 $61.8 Million - $73.9 Million	877,892 Added 47.63%	2,721,194 $220 Million
Q4 2017 Feb 01, 2018	SELL	$72.33 - $77.64 $1.02 Million - $1.1 Million	-14,133 Reduced 0.76%	1,843,302 $155 Million
Q3 2017 Nov 02, 2017	BUY	$74.14 - $77.27 $138 Million - $144 Million	1,857,435	1,857,435 $159 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.

Account